Harvard Bioscience, Inc. (HBIO)
5.38
+0.18
(+3.46%)
USD |
NASDAQ |
Apr 06, 10:51
Harvard Bioscience Market Cap : 24.58M for April 6, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Bio-Rad Laboratories, Inc. | 7.598B |
| Bruker Corp. | 5.678B |
| Azenta, Inc. | 1.117B |
| Bionano Genomics, Inc. | 12.97M |
| Avantor, Inc. | 5.485B |
Market Cap Related Metrics
| PS Ratio | 0.8927 |
| PEG Ratio | -0.0026 |
| Price to Book Value | 1.752 |
| Price to Free Cash Flow | 15.88 |
| Price | 5.38 |
| Earnings Yield | -47.79% |
| PEGY Ratio | -0.0026 |
| Operating PE Ratio | 772.60 |